DIAGNOS (CVE:ADK) Stock Price Down 1.5% – What’s Next?

DIAGNOS Inc. (CVE:ADK)’s stock price traded down 1.5% during mid-day trading on Tuesday . The company traded as low as C$0.33 and last traded at C$0.34. 103,500 shares changed hands during trading, an increase of 14% from the average session volume of 90,800 shares. The stock had previously closed at C$0.34.

Analyst Ratings Changes

Separately, Ventum Cap Mkts raised DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.

DIAGNOS Stock Performance

The business has a fifty day simple moving average of C$0.36 and a two-hundred day simple moving average of C$0.32. The company has a quick ratio of 0.68, a current ratio of 0.39 and a debt-to-equity ratio of 245.28. The company has a market cap of C$26.88 million, a P/E ratio of -8.38 and a beta of -0.44.

DIAGNOS (CVE:ADK) last posted its earnings results on Wednesday, August 21st. The company reported C($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of C($0.02) by C$0.01. The firm had revenue of C$0.04 million during the quarter, compared to the consensus estimate of C$0.07 million. On average, sell-side analysts anticipate that DIAGNOS Inc. will post -0.02 EPS for the current year.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.